The Nano-Bio Manufacturing Consortium is expected to grow the US-centric innovation ecosystem that will risk reduce material supply (including nanomaterials & biomaterials), processing techniques, and flexible/stretchable device concepts by demonstrating component- and system-level functionality

credit:

relevant to human-integrated technologies, such as airman-performance monitoring (APM) and augmentation (APA) systems.

This public-private partnership should build upon the foundation of research & development excellence that has been established within NBMC since its 2013 inception.

It is envisioned that technology development will require teaming between academia and industry in partnership with government researchers as well as with appropriate members of the regulatory and operational DoD communities.

A balance between enabling component- and systems-level prototype development is expected to be realized through end-technologies between TRL 3 and TRL 6.

It is expected that during the completion of certain NBMC projects, lab and/or field demonstrations will be conducted in partnership with relevant DoD partners to ensure that members of military human performance and/or aeromedical communities can assess the utility of developments and provide iterative feedback with respect to critical path issues.